A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer
Clinical trial NCT01983878 · COMPLETED
Trial details
- NCT number
- NCT01983878
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-01-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.